-
Xiaomi Pad 9 Pro Leak Suggests 12.5-Inch Display and Massive Battery
-
China's Xi and Iran's Pezeshkian in Kyrgyzstan, Putin expected
-
UK Homeowners Advised to Use Peppermint Tea Bags to Deter Spiders
-
Rescuers hunt for missing after deadly N.Cyprus ferry accident
-
Nepal toll surges as rescuers struggle through 'unimaginable' disaster
-
Ethiopia's Abiy could consolidate power as 'executive president'
-
Mauled Australian swimmer recalls punching shark
-
Crude prices rise on US-Iran strikes, equities mixed after Warsh remarks
-
Passengers stranded overnight by Kenya airport strike
-
South Korea court gives Unification Church leader 2 years prison
-
Nepal recovers bodies but presses on for trapped tunnel workers
-
US hosts G20 finance talks with growth, Iran pressure on agenda
-
Grand Canyon flash flood leaves one dead, around 15 missing
-
African players in Europe: Wissa flick seals Newcastle victory
-
Venus Williams falls at first hurdle in US Open
-
Venice film preview: Clooney, Oasis and Musk
-
At least five leaders skip annual Pacific Islands summit
-
Poorly Djokovic crashes out of US Open first round
-
I.Coast home-hunters' saga highlights Africa housing crunch
-
Djokovic falls in US Open first round, earliest Grand Slam exit in 20 years
-
At least five leaders to skip annual Pacific Islands summit
-
Chinese guitar capital's stairway to export heaven
-
Latest developments in the US-Iran war
-
Stocks drop as Warsh fans US rate hike bets, crude up on US-Iran strikes
-
Nepal buries dead as rescuers seek thousands missing
-
Injuries cloud tennis as US Open gets under way
-
From Montecito to the Cotswolds: Harry and Meghan eye new UK home
-
Iran retaliates after first US strikes in a month
-
Russia's Putin and China's Xi to attend summit in Kyrgyzstan
-
Itauma says 'I'll be back' after bruising heavyweight title loss
-
John Ternus to lead Apple into the age of AI
-
Brilliant Palou clinches fourth straight IndyCar crown
-
Trump calls for 'punishment' of NBC reporter
-
US strikes Iran for first time in a month, Tehran retaliates
-
About 15 people missing after Grand Canyon flash flood
-
Yin holds off Kim to win sixth LPGA title, end title drought
-
Medvedev advances without drama at US Open
-
Top-ranked Scheffler storms to PGA Tour Championship win
-
Calhanoglu fires Inter to nervy Cagliari win, Como stun Napoli
-
Root urges England to be 'grown-ups' after Pakistan series win
-
Monaco beat Marseille to go top, Rosenior's Paris FC thump Nice
-
Google Maps renames Lake Ontario 'Lake America' in US -- but not Canada
-
Pegula shakes off nerves in US Open first-round win
-
Aaron Donald ends retirement to rejoin Rams: team
-
FIFA president Infantino 'must go', says ex-UEFA boss Platini
-
Niamey back to normal after soldiers' mutiny
-
England v Pakistan second Test: Three talking points
-
Niger mutiny suppressed, but questions remain over junta's cohesion
-
Rashford's return 'fantastic' for Man Utd, says Carrick
-
Como spoil Allegri's Napoli home debut
Trump signs order to fast-track research on psychedelic drugs
US President Donald Trump on Saturday announced an easing of restrictions on research into psychedelic drugs -- such as so-called "magic mushrooms" -- that have shown promise in treating people with mental health conditions.
Flanked by US Health Secretary Robert F. Kennedy Jr, top medical officials and podcaster Joe Rogan, who has pushed for access to the drugs, Trump signed an executive order that would help federal researchers cut through the red tape to allow for quicker studies.
The president said the order would "clear away unnecessary bureaucratic hurdles, improve data sharing among the FDA (Food and Drug Administration) and the Department of Veterans Affairs and facilitate fast rescheduling of any psychedelic drugs that become FDA approved."
Currently, many psychedelics including LSD and psilocybin ("magic mushrooms") are classified -- or "scheduled" -- as having high abuse and addiction potential, and are not approved for medical use, limiting the ability for scientists to study them.
If the FDA, which is charged with regulating pharmaceuticals in the United States, officially finds a medical benefit for some of the psychedelics, they could be rescheduled, allowing for greater clinical use.
The order only provides for accelerated research and does not immediately require law enforcement authorities to reclassify the drugs, meaning therapeutic use will not expand immediately.
In recent years, there has been a growing push to research the effects of the drugs in treating people -- especially war veterans -- with difficult anxiety and depression cases, especially those who had experienced traumatic stress.
Many veterans and other patients have complained that traditional antidepressant cocktails not only fail to work but change their personalities in ways that alienate them from their friends and family.
In 2023, 6,398 veterans took their own lives, the Department of Veterans Affairs said.
During the signing ceremony at the White House, Trump pointed to one drug called ibogaine, claiming patients who had taken it "experienced an 80 to 90 percent reduction in symptoms of depression and anxiety within one month."
"Can I have some, please?" he joked.
The full extent of the benefits and potential side effects of psychedelic medications is not yet known, since research has been restricted.
While many are thought to show promising mental health benefits, there are risks. Ibogaine, for instance, is thought to potentially damage the heart.
If you are a US veteran in need of help, or concerned about one, you can dial 988 and press 1, or visit www.veteranscrisisline.net.
L.AbuAli--SF-PST